Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Medplus Health Services Limited, at its meeting held on March 16, 2026, approved the incorporation of a new Private Limited Company as a Wholly Owned Subsidiary (WOS). The new entity will be registered under Section 8 of the Companies Act, 2013, making it a not-for-profit company. It will be set up solely to undertake the company's CSR (Corporate Social Responsibility) activities. Medplus will hold 100% of the shareholding (including through nominees), with the subscription made at face value. The name of the new entity is yet to be approved by the Registrar of Companies, Hyderabad, and further disclosures will follow once the incorporation is complete.
This is a routine CSR-related corporate restructuring with no material impact on shareholders. The WOS will be a not-for-profit vehicle, so it is unlikely to affect the stock price, earnings, or dividends. Investors may view it neutrally as good corporate governance practice.